RSS
21 Nov 2019

iOmx Therapeutics’ iOTarg™ Genetic Screening Platform Featured in Podium Presentation at PEGS Europe 2019

Author: admintech | Filed under: Press Release

MARTINSRIED, Germany and MUNICH, Nov. 21, 2019 /PRNewswire/ — iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer therapeutics based on novel immune checkpoint targets, announced today that its Vice President, Antibody Development, Stefanie Urlinger, PhD, delivered…

This entry was posted on Thursday, November 21st, 2019 at 7:21 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»